Philips becomes first medical device manufacturer granted new Underwriters Laboratories product cybersecurity testing firm re...
March 12 2020 - 9:00AM
Philips becomes first medical device manufacturer granted new
Underwriters Laboratories product cybersecurity testing firm
registration
March 12, 2020
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,
AEX: PHIA), a global leader in health technology, today announced
that the company was named the first medical device manufacturer to
receive a new Underwriters Laboratories (UL) product cybersecurity
testing certification. Underwriters Laboratories (UL) is an
independent global safety certification and testing company with
locations worldwide.
The UL IEC 62304 certification was designed by Underwriters
Laboratories to provide an overall framework to evaluate the
robustness and maturity of a medical device manufacturer’s
cybersecurity controls and capabilities for product
development.
In support of the successful Philips firm registration for the
security option of IEC 62304, UL performed a comprehensive audit of
the Philips Security Center of Excellence. The Center was launched
in 2015 to develop cyber-resilient products and services through
security-by-design, risk assessment, vulnerability and penetration
assessment, specialized trainings, and incident response.
The audit reviewed and verified core Philips product security
processes, including security risk management and risk control
measures, software security verification planning, change
management and continuous improvement, and the Center’s laboratory
quality management system.
The UL certification combines cybersecurity testing elements of
the established UL 2900-2-1 standard for Software Cybersecurity for
Network-Connectable Products, which focuses on the demanding
requirements of healthcare and wellness systems, as well as
security principles from international standards (ISO 13485 and ISO
14971).
“To receive this certification from Underwriters Laboratories, a
long-established global leader in standards creation and safety
testing, is a strong validation of our program and an opportunity
to advance healthcare and personal health product security even
further,” said Michael McNeil, Global Product Security &
Services Officer, Philips.
“We’ve spent years building a successful and effective
end-to-end Security by Design program, embedding security
principles and best practices throughout a product’s life cycle,”
McNeil added. “At Philips, we understand that our customers have
high and growing expectations for the security of the solutions
that they rely on. In addition, global regulatory authorities have
also increased the scope and scale of product cybersecurity
compliance requirements to help protect patients and consumers. We
look forward to continuing to meet these critical commitments.”
For further information, please contact:
Mario FantePhilips Global Press OfficeTel: +1
603-560=9226E-mail: mario.fante@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 80,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Cockpit with clinicians talking
- UL Registered Firm Mark
- Michael McNeil, Global Product Security & Services Officer,
Philips
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024